Shortcuts

open access

Vol 6, No 3 (2007)
Original articles
Published online: 2007-11-07
Get Citation

The incidence of chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients

Joanna Maria Jassem, Maciej Bobowicz, Jan Marek Slominski, Ewa Jassem
Advances in Palliative Medicine 2007;6(3):99-102.

open access

Vol 6, No 3 (2007)
Original articles
Published online: 2007-11-07

Abstract

Background and aim. Lung cancer is one of the most common tumours and the cause of cancer-related deaths in European countries. In the past few years, a significant morbidity of chronic obstructive pulmonary disease (COPD) has been noticed in this group of patients. Cigarette smoking is the strongest risk factor for both conditions. The palliative care of lung cancer patients is often based solely on the tumour symptoms' management, whereas some patients would benefit from the combined treatment including the treatment for COPD. The aim of this study was to evaluate the incidence of COPD in advanced (TNM = IIIB and IV) non-small cell lung cancer (NSCLC) patients.
Material and methods. The study was a retrospective analysis. One hundred four patients (28 women and 76 men, aged from 47 to 74 years, mean: 63.2 years) with advanced NSCLC were included in the study.
Results. Chronic obstructive pulmonary disease (according to GOLD criteria) was diagnosed in 26 cases (25%), including 1 mild, 17 moderate and 8 with severe or very severe disease. Chronic obstructive pulmonary disease was significantly more frequent in squamous cell lung carcinoma in comparison to other types (p = 0.009).
Conclusions. Coexistence of lung cancer and COPD is frequent. Therefore, it is important to consider the treatment for COPD in palliative care of advanced lung cancer patients.

Abstract

Background and aim. Lung cancer is one of the most common tumours and the cause of cancer-related deaths in European countries. In the past few years, a significant morbidity of chronic obstructive pulmonary disease (COPD) has been noticed in this group of patients. Cigarette smoking is the strongest risk factor for both conditions. The palliative care of lung cancer patients is often based solely on the tumour symptoms' management, whereas some patients would benefit from the combined treatment including the treatment for COPD. The aim of this study was to evaluate the incidence of COPD in advanced (TNM = IIIB and IV) non-small cell lung cancer (NSCLC) patients.
Material and methods. The study was a retrospective analysis. One hundred four patients (28 women and 76 men, aged from 47 to 74 years, mean: 63.2 years) with advanced NSCLC were included in the study.
Results. Chronic obstructive pulmonary disease (according to GOLD criteria) was diagnosed in 26 cases (25%), including 1 mild, 17 moderate and 8 with severe or very severe disease. Chronic obstructive pulmonary disease was significantly more frequent in squamous cell lung carcinoma in comparison to other types (p = 0.009).
Conclusions. Coexistence of lung cancer and COPD is frequent. Therefore, it is important to consider the treatment for COPD in palliative care of advanced lung cancer patients.
Get Citation

Keywords

advanced lung cancer; NSCLC; chronic obstructive pulmonary disease; pulmonary function tests; spirometry

About this article
Title

The incidence of chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients

Journal

Advances in Palliative Medicine

Issue

Vol 6, No 3 (2007)

Pages

99-102

Published online

2007-11-07

Bibliographic record

Advances in Palliative Medicine 2007;6(3):99-102.

Keywords

advanced lung cancer
NSCLC
chronic obstructive pulmonary disease
pulmonary function tests
spirometry

Authors

Joanna Maria Jassem
Maciej Bobowicz
Jan Marek Slominski
Ewa Jassem

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl